$68.37
al cierre: Nov 12 EDT
$68.10
-0.27-0.39%
Pre-comercialización: 4:48 PM EDT
Comments
Loading...
Exact Sciences Actividad de operaciones con información privilegiada
EXASNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Exact Sciences. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Exact Sciences.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Exact Sciences Corp los iniciados?
En Exact Sciences Corp, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders han informado que han vendido un total de 16.36K acciones por valor de $1.09M, mientras tanto, los insiders han no reportar compras en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El octubre 10, 2025, James Herriott, la empresa SVP, GENERAL COUNSEL & SEC sold 1.5K acciones por $60 cada una.
- El noviembre 6, 2025, James Herriott, la empresa SVP, GENERAL COUNSEL & SEC sold 1.5K acciones por $70.08 cada una.
- El octubre 10, 2025, James Edward Doyle, la empresa - sold 2K acciones por $60 cada una.
Estadísticas de propiedad de Exact Sciences Corp
Acciones en circulación
189.471M
Acciones en manos de personas con información privilegiada
3.945M
Porcentaje de acciones en manos de personas con información privilegiada
2.09%
Acciones en manos de instituciones
145.403M
Porcentaje de acciones en manos de instituciones
76.7%
Nov 06, 2025 | SVP, GENERAL COUNSEL & SEC | -1.50K | $70.08 | -$105.12K | SELL | -9.59% | 14.14K | Nov 04 | ||
Nov 06, 2025 | EVP, GM, PRECISION ONCOLOGY | -2.86K | $70.08 | -$200.29K | SELL | -11.04% | 23.04K | Nov 04 | ||
Oct 27, 2025 | — | -12.00K | $65.00 | -$780.00K | SELL | -16.49% | 60.76K | Oct 24 | ||
Oct 10, 2025 | SVP, GENERAL COUNSEL & SEC | -1.50K | $60.00 | -$90.00K | SELL | -8.75% | 15.64K | Oct 09 | ||
Oct 10, 2025 | — | -2.00K | $60.00 | -$120.00K | SELL | -3.34% | 57.96K | Oct 09 | ||
Aug 14, 2025 | — | -1.49K | $42.02 | -$62.40K | SELL | -2.42% | 59.96K | Aug 13 | ||
Jun 16, 2025 | — | 2.19K | $53.20 | -$170.61K | GRANT | 3.10% | 72.76K | Jun 12 - Jun 13 | ||
Nov 13, 2024 | PRESIDENT AND CEO | 19.50K | $51.35 | $1.00M | BUY | 1.69% | 1.18M | Nov 13 | ||
Oct 09, 2024 | EVP, GM, PRECISION ONCOLOGY | -929.00 | $70.00 | -$65.03K | SELL | -6.57% | 13.21K | Oct 08 | ||
Sep 19, 2024 | EVP, GM, PRECISION ONCOLOGY | -929.00 | $70.00 | -$65.03K | SELL | -6.16% | 14.14K | Sep 18 | ||
May 02, 2024 | — | 151.00 | $60.15 | -$4.03K | GRANT | 0.31% | 49.34K | Apr 30 - May 01 | ||
May 02, 2024 | CHIEF COMMERCIAL OFFICER | 863.00 | $45.09 | $13.07K | GRANT | 1.85% | 47.61K | Apr 30 - May 01 | ||
May 02, 2024 | SVP, GENERAL COUNSEL & SEC | 741.00 | $45.09 | $19.45K | GRANT | 7.19% | 11.05K | Apr 30 - May 01 | ||
May 02, 2024 | CHIEF FINANCIAL OFFICER | 862.00 | $45.09 | $13.04K | GRANT | 6.89% | 13.38K | Apr 30 - May 01 | ||
May 02, 2024 | EVP, GM., PRECISION ONCOLOGY | 108.00 | $60.15 | -$6.62K | GRANT | 0.79% | 13.73K | Apr 30 - May 01 | ||
May 02, 2024 | EVP, HUMAN RESOURCES | 824.00 | $45.09 | $15.12K | GRANT | 1.06% | 78.34K | Apr 30 - May 01 | ||
May 02, 2024 | GENERAL MANAGER, SCREENING | 116.00 | $60.15 | -$6.14K | GRANT | 0.75% | 15.56K | Apr 30 - May 01 | ||
May 02, 2024 | PRESIDENT AND CEO | 2.04K | $45.09 | -$48.22K | GRANT | 0.17% | 1.18M | Apr 30 - May 01 | ||
Apr 03, 2024 | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.52% | 77.51K | Apr 01 | ||
Apr 03, 2024 | EVP, GM., PRECISION ONCOLOGY | -924.00 | $79.43 | -$73.39K | SELL | -6.35% | 13.63K | Apr 02 | ||
Apr 01, 2024 | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.45% | 79.51K | Mar 28 | ||
Mar 04, 2024 | GENERAL MANAGER, SCREENING | 2.57K | $59.32 | -$127.78K | SELL-OPTIONS | 19.97% | 15.44K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | DIRECTOR | -5.00K | $57.50 | -$287.50K | SELL | -17.87% | 22.98K | Mar 01 | ||
Mar 04, 2024 | GENERAL COUNSEL | 1.03K | $59.32 | -$51.13K | SELL-OPTIONS | 11.08% | 10.31K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | CHIEF FINANCIAL OFFICER | 2.88K | $59.32 | -$143.08K | SELL-OPTIONS | 29.87% | 12.52K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | DIRECTOR | -2.00K | $57.50 | -$115.00K | SELL | -3.84% | 50.11K | Mar 01 | ||
Mar 04, 2024 | CHIEF COMMERCIAL OFFICER | 2.88K | $59.32 | -$143.08K | SELL-OPTIONS | 6.56% | 46.75K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | PRESIDENT AND CEO | 9.87K | $59.32 | -$490.64K | SELL-OPTIONS | 0.75% | 1.32M | Feb 29 - Mar 01 | ||
Mar 04, 2024 | EVP, HUMAN RESOURCES | 2.06K | $59.32 | -$102.27K | SELL-OPTIONS | 2.59% | 81.51K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | GEN. MGR., PRECISION ONCOLOGY | 2.40K | $59.32 | -$137.80K | SELL-OPTIONS | 19.76% | 14.55K | Feb 29 - Mar 01 | ||
Feb 28, 2024 | GENERAL MANAGER, SCREENING | 2.08K | $56.89 | -$106.90K | SELL-OPTIONS | 19.22% | 12.87K | Feb 26 - Feb 27 | ||
Feb 28, 2024 | GENERAL COUNSEL | 864.00 | $56.89 | -$44.60K | SELL-OPTIONS | 10.27% | 9.28K | Feb 26 - Feb 27 | ||
Feb 28, 2024 | CHIEF COMMERCIAL OFFICER | 4.03K | $56.89 | -$207.53K | SELL-OPTIONS | 10.12% | 43.87K | Feb 26 - Feb 27 | ||
Feb 28, 2024 | CHIEF FINANCIAL OFFICER | 2.99K | $56.89 | -$154.17K | SELL-OPTIONS | 44.99% | 9.64K | Feb 26 - Feb 27 | ||
Feb 28, 2024 | PRESIDENT AND CEO | 6.92K | $56.89 | -$356.30K | SELL-OPTIONS | 0.53% | 1.31M | Feb 26 - Feb 27 | ||
Feb 28, 2024 | EVP, HUMAN RESOURCES | 2.07K | $56.89 | -$106.95K | SELL-OPTIONS | 2.68% | 79.46K | Feb 26 - Feb 27 | ||
Feb 28, 2024 | GEN. MGR., PRECISION ONCOLOGY | 1.93K | $56.89 | -$115.32K | SELL-OPTIONS | 18.85% | 12.15K | Feb 26 - Feb 27 | ||
Feb 26, 2024 | EVP, HUMAN RESOURCES | -1.02K | $59.72 | -$60.97K | SELL | -1.30% | 77.38K | Feb 23 | ||
Feb 23, 2024 | GENERAL MANAGER, SCREENING | 1.02K | $59.78 | -$60.56K | GRANT | 10.45% | 10.80K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | GENERAL COUNSEL | 290.00 | $59.78 | -$17.40K | GRANT | 3.57% | 8.42K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | CHIEF FINANCIAL OFFICER | 1.36K | $59.78 | -$80.76K | GRANT | 25.72% | 6.65K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | CHIEF COMMERCIAL OFFICER | 1.36K | $59.78 | -$80.70K | GRANT | 3.54% | 39.84K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | DIRECTOR | 1.37K | $59.78 | -$39.63K | GRANT | 2.87% | 49.19K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | PRESIDENT AND CEO | 11.67K | $59.78 | -$691.36K | GRANT | 0.93% | 1.26M | Feb 21 - Feb 22 | ||
Feb 23, 2024 | EVP, HUMAN RESOURCES | 1.02K | $59.78 | -$60.56K | GRANT | 1.32% | 78.41K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | GEN. MGR., PRECISION ONCOLOGY | 941.00 | $59.78 | -$65.34K | GRANT | 10.14% | 10.22K | Feb 21 - Feb 22 | ||
Feb 22, 2024 | GENERAL MANAGER, SCREENING | 1.17K | $61.50 | -$66.30K | SELL-OPTIONS | 13.60% | 9.78K | Feb 20 - Feb 21 | ||
Feb 22, 2024 | GENERAL COUNSEL | 449.00 | $61.50 | -$25.52K | SELL-OPTIONS | 5.85% | 8.13K | Feb 20 - Feb 21 | ||
Feb 22, 2024 | CHIEF FINANCIAL OFFICER | 1.62K | $61.50 | -$91.82K | SELL-OPTIONS | 44.13% | 5.29K | Feb 20 - Feb 21 | ||
Feb 22, 2024 | DIRECTOR | 1.54K | $61.50 | -$43.42K | SELL-OPTIONS | 3.33% | 47.82K | Feb 20 - Feb 21 | ||
Feb 22, 2024 | PRESIDENT AND CEO | 5.40K | $61.50 | -$305.96K | SELL-OPTIONS | 0.43% | 1.25M | Feb 20 - Feb 21 | ||
Feb 22, 2024 | EVP, HUMAN RESOURCES | 1.17K | $61.50 | -$66.36K | SELL-OPTIONS | 1.53% | 77.38K | Feb 20 - Feb 21 | ||
Feb 22, 2024 | GEN. MGR., PRECISION ONCOLOGY | 834.00 | $61.50 | -$55.04K | SELL-OPTIONS | 9.87% | 9.28K | Feb 20 - Feb 21 | ||
Feb 16, 2024 | GENERAL MANAGER, SCREENING | 1.06K | $61.43 | -$59.34K | SELL-OPTIONS | 14.71% | 8.30K | Feb 14 - Feb 15 | ||
Feb 16, 2024 | GENERAL COUNSEL | 530.00 | $45.73 | -$23.82K | SELL-OPTIONS | 7.74% | 7.38K | Oct 31 - Feb 15 | ||
Feb 16, 2024 | CHIEF FINANCIAL OFFICER | 2.08K | $61.43 | -$115.98K | SELL-OPTIONS | 158.72% | 3.40K | Feb 14 - Feb 15 | ||
Feb 16, 2024 | DIRECTOR | 2.60K | $61.43 | -$84.53K | SELL-OPTIONS | 5.94% | 46.27K | Feb 14 - Feb 15 | ||
Feb 16, 2024 | PRESIDENT AND CEO | 17.05K | $45.73 | -$887.33K | SELL-OPTIONS | 1.39% | 1.25M | May 01 - Feb 15 | ||
Feb 16, 2024 | EVP, HUMAN RESOURCES | 1.07K | $61.43 | -$59.28K | SELL-OPTIONS | 1.42% | 75.91K | Feb 14 - Feb 15 | ||
Jan 04, 2024 | EVP, HUMAN RESOURCES | -2.00K | $73.50 | -$147.00K | SELL | -2.60% | 74.85K | Jan 02 | ||
Jan 04, 2024 | GEN. MGR., PRECISION ONCOLOGY | -879.00 | $73.50 | -$64.61K | SELL | -9.59% | 8.29K | Jan 02 | ||
Dec 18, 2023 | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.54% | 76.85K | Dec 14 | ||
Oct 13, 2023 | CHIEF COMMERCIAL OFFICER | 15.21K | $48.25 | -$843.55K | SELL-OPTIONS | 66.19% | 38.18K | May 01 - Oct 12 | ||
Sep 06, 2023 | EVP, HUMAN RESOURCES | -6.89K | $84.36 | -$379.62K | SELL | -8.04% | 78.85K | Sep 01 | ||
Aug 23, 2023 | CHIEF FINANCIAL OFFICER | -29.24K | $58.80 | -$2.47M | SELL | -95.70% | 1.31K | May 02 - Aug 21 | ||
Aug 08, 2023 | GEN. MGR., PRECISION ONCOLOGY | 1.36K | $85.04 | -$114.80K | SELL-OPTIONS | 17.45% | 9.17K | Aug 04 - Aug 07 | ||
Jul 28, 2023 | DIRECTOR | -2.00K | $97.42 | -$194.84K | SELL | -3.70% | 52.11K | Jul 27 | ||
Jul 21, 2023 | GENERAL COUNSEL | -1.30K | $100.00 | -$130.00K | SELL | -15.96% | 6.84K | Jul 19 | ||
Jun 12, 2023 | DIRECTOR | 2.20K | $90.51 | -$126.90K | GRANT | 4.23% | 54.11K | Jun 08 - Jun 09 | ||
Jun 12, 2023 | DIRECTOR | 572.00 | $90.51 | -$273.97K | GRANT | 0.89% | 64.63K | Jun 08 - Jun 09 | ||
Jun 12, 2023 | GENERAL COUNSEL | -1.30K | $90.00 | -$117.00K | SELL | -13.76% | 8.14K | Jun 08 | ||
May 31, 2023 | DIRECTOR | -2.00K | $80.62 | -$161.24K | SELL | -3.71% | 51.91K | May 26 | ||
May 12, 2023 | EVP, HUMAN RESOURCES | -6.09K | $80.00 | -$486.96K | SELL | -6.63% | 85.74K | May 10 | ||
May 12, 2023 | GENERAL MANAGER, SCREENING | -5.00K | $80.00 | -$400.00K | SELL | -40.86% | 7.24K | May 10 | ||
May 12, 2023 | GENERAL COUNSEL | -660.00 | $54.93 | -$84.59K | SELL | -6.53% | 9.45K | May 01 - May 10 | ||
May 03, 2023 | EVP, HUMAN RESOURCES | -291.00 | $46.90 | -$42.50K | SELL | -0.32% | 91.83K | Apr 30 - May 01 | ||
Apr 05, 2023 | EVP, HUMAN RESOURCES | -1.00K | $67.19 | -$67.19K | SELL | -1.07% | 92.12K | Apr 03 | ||
Mar 07, 2023 | GENERAL MANAGER, SCREENING | -5.00K | $65.00 | -$325.00K | SELL | -29.47% | 11.97K | Mar 03 | ||
Mar 02, 2023 | CHIEF COMMERCIAL OFFICER | -3.63K | $62.01 | -$224.97K | SELL | -13.78% | 22.70K | Mar 01 | ||
Mar 02, 2023 | EVP, HUMAN RESOURCES | -1.00K | $62.00 | -$62.00K | SELL | -1.07% | 92.85K | Mar 01 | ||
Mar 01, 2023 | CHIEF FINANCIAL OFFICER | 4.90K | $61.12 | -$258.72K | SELL-OPTIONS | 19.15% | 30.51K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | GENERAL COUNSEL | -338.00 | $60.43 | -$134.45K | SELL | -3.32% | 9.84K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | GENERAL MANAGER, SCREENING | -2.88K | $60.29 | -$411.87K | SELL | -14.50% | 16.97K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | DIRECTOR | 5.04K | $61.12 | -$253.83K | SELL-OPTIONS | 15.67% | 37.20K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | EVP, HUMAN RESOURCES | 3.39K | $61.12 | -$178.71K | SELL-OPTIONS | 3.74% | 93.85K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | GEN. MGR., PRECISION ONCOLOGY | 2.02K | $61.12 | -$118.08K | SELL-OPTIONS | 35.81% | 7.67K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | PRESIDENT AND CEO | 12.08K | $61.12 | -$636.63K | SELL-OPTIONS | 0.99% | 1.23M | Feb 27 - Feb 28 | ||
Feb 23, 2023 | PRESIDENT AND CEO | 5.61K | $62.72 | -$298.80K | SELL-OPTIONS | 0.46% | 1.22M | Feb 21 - Feb 22 | ||
Feb 23, 2023 | GENERAL COUNSEL | 467.00 | $62.72 | -$24.96K | SELL-OPTIONS | 4.81% | 10.17K | Feb 21 - Feb 22 | ||
Feb 23, 2023 | GENERAL MANAGER, SCREENING | 3.19K | $62.72 | -$169.97K | SELL-OPTIONS | 19.13% | 19.85K | Feb 21 - Feb 22 | ||
Feb 23, 2023 | EVP, HUMAN RESOURCES | 1.22K | $62.72 | -$64.79K | SELL-OPTIONS | 1.36% | 90.46K | Feb 21 - Feb 22 | ||
Feb 23, 2023 | DIRECTOR | 1.24K | $62.72 | -$63.16K | SELL-OPTIONS | 4.01% | 32.16K | Feb 21 - Feb 22 | ||
Feb 23, 2023 | CHIEF FINANCIAL OFFICER | 1.68K | $62.72 | -$89.69K | SELL-OPTIONS | 7.03% | 25.60K | Feb 21 - Feb 22 | ||
Feb 23, 2023 | GEN. MGR., PRECISION ONCOLOGY | 891.00 | $62.72 | -$52.56K | SELL-OPTIONS | 18.74% | 5.65K | Feb 21 - Feb 22 | ||
Feb 17, 2023 | EVP, HUMAN RESOURCES | -1.08K | $63.91 | -$68.77K | SELL | -1.19% | 89.25K | Feb 16 | ||
Feb 16, 2023 | GENERAL COUNSEL | 483.00 | $65.59 | -$26.24K | SELL-OPTIONS | 5.24% | 9.71K | Feb 14 - Feb 15 | ||
Feb 16, 2023 | EVP, HUMAN RESOURCES | 1.08K | $65.59 | -$62.57K | SELL-OPTIONS | 1.21% | 90.32K | Feb 14 - Feb 15 | ||
Feb 16, 2023 | GENERAL MANAGER, SCREENING | 1.08K | $69.59 | -$66.39K | SELL-OPTIONS | 6.90% | 16.66K | Feb 14 - Feb 15 | ||
Feb 16, 2023 | DIRECTOR | 2.15K | $65.59 | -$119.44K | SELL-OPTIONS | 7.48% | 30.92K | Feb 14 - Feb 15 | ||
Feb 16, 2023 | CHIEF FINANCIAL OFFICER | 2.11K | $65.59 | -$122.39K | SELL-OPTIONS | 9.65% | 23.92K | Feb 14 - Feb 15 | ||
Feb 16, 2023 | PRESIDENT AND CEO | 16.52K | $65.59 | -$958.73K | SELL-OPTIONS | 1.38% | 1.21M | Feb 14 - Feb 15 | ||
Feb 14, 2023 | CHIEF FINANCIAL OFFICER | 1.42K | $64.55 | -$74.75K | SELL-OPTIONS | 6.97% | 21.82K | Feb 10 - Feb 13 | ||
Feb 14, 2023 | PRESIDENT AND CEO | 5.18K | $64.55 | -$292.22K | SELL-OPTIONS | 0.44% | 1.19M | Feb 10 - Feb 13 | ||
Feb 03, 2023 | EVP, HUMAN RESOURCES | -1.00K | $67.93 | -$67.93K | SELL | -1.11% | 89.25K | Feb 01 | ||
Jan 11, 2023 | EVP, HUMAN RESOURCES | -672.00 | $53.70 | -$44.45K | SELL | -0.74% | 90.25K | May 02 - Jan 09 | ||
Oct 13, 2022 | CHIEF COMMERCIAL OFFICER | 18.65K | $39.39 | -$504.62K | SELL-OPTIONS | ∞ | 18.65K | May 02 - Oct 12 | ||
Aug 08, 2022 | GEN. MGR., PRECISION ONCOLOGY | 1.73K | $47.12 | -$46.37K | SELL-OPTIONS | 57.09% | 4.75K | Aug 04 - Aug 05 | ||
Jul 28, 2022 | DIRECTOR | 0.00 | $27.66 | -$161.10K | SELL-OPTIONS | 0.00% | 64.06K | Jul 26 | ||
Jul 06, 2022 | PRESIDENT AND CEO | 321.00 | $44.08 | $15.27K | GRANT | 0.03% | 1.19M | May 02 - Jul 01 | ||
Jul 01, 2022 | DIRECTOR | -1.09K | $40.13 | -$43.58K | SELL | -1.67% | 64.06K | Jun 30 | ||
Mar 02, 2022 | EVP, HUMAN RESOURCES | 3.06K | $76.69 | -$215.96K | SELL-OPTIONS | 3.50% | 90.68K | Feb 28 - Mar 01 | ||
Mar 02, 2022 | PRESIDENT AND CEO | 15.59K | $76.69 | -$1.10M | SELL-OPTIONS | 1.66% | 952.71K | Feb 28 - Mar 01 | ||
Mar 02, 2022 | CHIEF LEGAL OFFICER | 4.38K | $76.69 | -$300.01K | SELL-OPTIONS | 27.26% | 20.43K | Feb 28 - Mar 01 | ||
Mar 02, 2022 | CHIEF FINANCIAL OFFICER | 4.41K | $76.69 | -$310.59K | SELL-OPTIONS | 27.74% | 20.32K | Feb 28 - Mar 01 | ||
Mar 01, 2022 | SVP, HUMAN RESOURCES | -5.48K | $74.19 | -$406.54K | SELL | -5.89% | 87.62K | Feb 25 | ||
Feb 25, 2022 | SVP, HUMAN RESOURCES | 5.48K | $70.10 | -$330.66K | SELL-OPTIONS | 6.25% | 93.10K | Feb 23 - Feb 24 | ||
Feb 25, 2022 | PRESIDENT AND CEO | 31.52K | $70.10 | -$1.90M | SELL-OPTIONS | 3.48% | 937.13K | Feb 23 - Feb 24 | ||
Feb 25, 2022 | CHIEF ADMINISTRATIVE OFFICER | 6.93K | $70.10 | -$407.63K | SELL-OPTIONS | 76.01% | 16.05K | Feb 23 - Feb 24 | ||
Feb 25, 2022 | CHIEF FINANCIAL OFFICER | 6.85K | $70.10 | -$413.38K | SELL-OPTIONS | 75.64% | 15.91K | Feb 23 - Feb 24 | ||
Feb 25, 2022 | GENERAL MANAGER, NEW VENTURES | 5.48K | $70.10 | -$330.66K | SELL-OPTIONS | 55.53% | 15.35K | Feb 23 - Feb 24 | ||
Feb 24, 2022 | CHIEF FINANCIAL OFFICER | 1.55K | $69.05 | -$107.51K | SELL-OPTIONS | 20.73% | 9.06K | Feb 22 - Feb 23 | ||
Feb 24, 2022 | SVP, HUMAN RESOURCES | 1.12K | $69.05 | -$77.61K | SELL-OPTIONS | 1.30% | 87.62K | Feb 22 - Feb 23 | ||
Feb 24, 2022 | PRESIDENT AND CEO | 5.18K | $69.05 | -$358.23K | SELL-OPTIONS | 0.58% | 905.61K | Feb 22 - Feb 23 | ||
Feb 24, 2022 | GENERAL MANAGER, NEW VENTURES | 1.12K | $69.05 | -$77.68K | SELL-OPTIONS | 12.83% | 9.87K | Feb 22 - Feb 23 | ||
Feb 24, 2022 | CHIEF ADMINISTRATIVE OFFICER | 1.14K | $69.05 | -$76.58K | SELL-OPTIONS | 14.26% | 9.12K | Feb 22 - Feb 23 | ||
Feb 23, 2022 | GENERAL MANAGER, NEW VENTURES | 1.90K | $73.42 | $143.31K | SELL-OPTIONS | 27.75% | 8.75K | Feb 18 - Feb 22 | ||
Feb 16, 2022 | SVP, HUMAN RESOURCES | 1.09K | $78.94 | $84.39K | SELL-OPTIONS | 1.28% | 86.50K | Feb 14 - Feb 15 | ||
Feb 16, 2022 | CHIEF FINANCIAL OFFICER | 2.13K | $78.94 | $164.83K | SELL-OPTIONS | 39.74% | 7.50K | Feb 14 - Feb 15 | ||
Feb 16, 2022 | PRESIDENT AND CEO | 207.91K | $49.54 | $3.20M | SELL-OPTIONS | 30.02% | 900.42K | Feb 14 - Feb 15 | ||
Feb 16, 2022 | GENERAL MANAGER, NEW VENTURES | 1.09K | $78.94 | $84.23K | SELL-OPTIONS | 18.93% | 6.85K | Feb 14 - Feb 15 | ||
Feb 16, 2022 | CHIEF ADMINISTRATIVE OFFICER | 2.49K | $78.42 | $188.14K | SELL-OPTIONS | 45.26% | 7.98K | Apr 30 - Feb 15 | ||
Nov 03, 2021 | PRESIDENT AND CEO | -16.92K | $93.88 | -$1.59M | SELL | -2.41% | 686.11K | Nov 01 | ||
Oct 05, 2021 | PRESIDENT AND CEO | -17.08K | $93.64 | -$1.60M | SELL | -2.37% | 703.03K | Oct 01 | ||
Sep 03, 2021 | PRESIDENT AND CEO | -18.98K | $104.42 | -$1.98M | SELL | -2.57% | 720.11K | Sep 01 | ||
Aug 04, 2021 | PRESIDENT AND CEO | -19.97K | $107.50 | -$2.15M | SELL | -2.63% | 739.09K | Aug 02 | ||
Aug 02, 2021 | CHIEF FINANCIAL OFFICER | -38.16K | $107.31 | -$4.25M | SELL | -96.47% | 1.40K | Apr 30 - Jul 29 | ||
Aug 02, 2021 | DIRECTOR | -1.38K | $111.11 | -$153.44K | SELL | -2.27% | 59.54K | Jul 30 | ||
Aug 02, 2021 | DIRECTOR | -2.64K | $111.17 | -$293.49K | SELL | -8.13% | 29.83K | Jul 30 | ||
Jul 06, 2021 | PRESIDENT AND CEO | -7.78K | $123.43 | -$960.78K | SELL | -1.02% | 759.06K | Jul 01 | ||
Jun 11, 2021 | SVP, HUMAN RESOURCES | -3.17K | $66.81 | -$622.96K | SELL | -4.02% | 75.80K | Apr 30 - Jun 10 | ||
Jun 03, 2021 | PRESIDENT AND CEO | -12.38K | $111.00 | -$1.37M | SELL | -1.59% | 766.84K | Jun 01 | ||
Jun 03, 2021 | DIRECTOR | -17.00K | $108.11 | -$1.84M | SELL | -76.26% | 5.29K | Jun 02 | ||
May 05, 2021 | PRESIDENT AND CEO | -18.91K | $97.91 | -$2.50M | SELL | -2.37% | 779.23K | Apr 30 - May 03 | ||
Apr 05, 2021 | PRESIDENT AND CEO | -22.75K | $132.30 | -$3.01M | SELL | -2.77% | 798.14K | Apr 01 | ||
Mar 15, 2021 | CHIEF SCIENCE OFFICER | 0.00 | $78.03 | -$4.49M | SELL-OPTIONS | 0.00% | 43.04K | Mar 11 | ||
Mar 08, 2021 | CHIEF SCIENCE OFFICER | -11.73K | $121.33 | -$1.42M | SELL | -23.39% | 38.43K | Mar 05 | ||
Mar 05, 2021 | CHIEF FINANCIAL OFFICER | -2.63K | $135.02 | -$355.37K | SELL | -6.24% | 39.55K | Mar 03 | ||
Mar 05, 2021 | CHIEF ADMINISTRATIVE OFFICER | -2.66K | $135.02 | -$359.69K | SELL | -32.65% | 5.50K | Mar 03 | ||
Mar 03, 2021 | CHIEF SCIENCE OFFICER | 2.50K | $138.42 | -$349.37K | SELL-OPTIONS | 5.25% | 50.16K | Mar 01 - Mar 02 | ||
Mar 03, 2021 | CHIEF FINANCIAL OFFICER | 795.00 | $139.24 | -$588.99K | SELL-OPTIONS | 1.92% | 42.14K | Mar 01 - Mar 02 | ||
Mar 03, 2021 | CHIEF ADMINISTRATIVE OFFICER | 899.00 | $139.23 | -$574.46K | SELL-OPTIONS | 12.59% | 8.04K | Mar 01 - Mar 02 | ||
Mar 03, 2021 | PRESIDENT AND CEO | 10.78K | $138.42 | -$1.36M | SELL-OPTIONS | 1.33% | 820.89K | Mar 01 - Mar 02 | ||
Mar 03, 2021 | SVP, HUMAN RESOURCES | 1.85K | $138.42 | -$232.41K | SELL-OPTIONS | 2.40% | 78.85K | Mar 01 - Mar 02 | ||
Mar 02, 2021 | DIRECTOR | -8.91K | $78.55 | -$2.20M | SELL | -77.70% | 2.56K | Feb 26 | ||
Mar 02, 2021 | CHIEF SCIENCE OFFICER | 1.66K | $137.44 | -$220.32K | SELL-OPTIONS | 3.61% | 47.66K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | CHIEF FINANCIAL OFFICER | -4.97K | $136.91 | -$1.15M | SELL | -10.72% | 41.34K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | SVP, HUMAN RESOURCES | 1.26K | $137.44 | -$150.91K | SELL-OPTIONS | 1.66% | 77.01K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | DIRECTOR | -2.00K | $130.11 | -$260.22K | SELL | -6.16% | 30.46K | Feb 26 | ||
Mar 02, 2021 | CHIEF ADMINISTRATIVE OFFICER | 1.76K | $90.67 | -$591.74K | SELL-OPTIONS | 32.84% | 7.14K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | PRESIDENT AND CEO | -21.98K | $136.88 | -$4.28M | SELL | -2.64% | 810.11K | Feb 26 - Mar 01 | ||
Mar 01, 2021 | CHIEF ADMINISTRATIVE OFFICER | -6.79K | $132.96 | -$902.53K | SELL | -55.81% | 5.37K | Feb 25 | ||
Feb 25, 2021 | CHIEF SCIENCE OFFICER | 5.73K | $136.30 | -$796.26K | SELL-OPTIONS | 14.24% | 46.00K | Feb 23 - Feb 24 | ||
Feb 25, 2021 | CHIEF FINANCIAL OFFICER | 4.85K | $136.30 | -$606.40K | SELL-OPTIONS | 11.70% | 46.31K | Feb 23 - Feb 24 | ||
Feb 25, 2021 | CHIEF ADMINISTRATIVE OFFICER | 6.79K | $79.07 | -$2.98M | SELL-OPTIONS | 126.31% | 12.16K | Feb 23 - Feb 24 | ||
Feb 25, 2021 | PRESIDENT AND CEO | 17.91K | $136.30 | -$2.24M | SELL-OPTIONS | 2.20% | 832.09K | Feb 23 - Feb 24 | ||
Feb 25, 2021 | SVP, HUMAN RESOURCES | 2.24K | $136.30 | -$280.37K | SELL-OPTIONS | 3.05% | 75.75K | Feb 23 - Feb 24 | ||
Feb 22, 2021 | GENERAL MANAGER, NEW VENTURES | 1.95K | $143.38 | -$243.17K | SELL-OPTIONS | 53.03% | 5.64K | Feb 18 - Feb 19 | ||
Feb 22, 2021 | CHIEF ADMINISTRATIVE OFFICER | -1.98K | $140.79 | -$278.76K | SELL | -26.92% | 5.37K | Feb 18 | ||
Feb 18, 2021 | GENERAL MANAGER, NEW VENTURES | 997.00 | $142.66 | -$147.37K | SELL-OPTIONS | 37.12% | 3.68K | Feb 16 - Feb 17 | ||
Feb 18, 2021 | CHIEF SCIENCE OFFICER | 1.84K | $142.66 | -$304.01K | SELL-OPTIONS | 4.79% | 40.27K | Feb 16 - Feb 17 | ||
Feb 18, 2021 | CHIEF FINANCIAL OFFICER | 1.95K | $142.66 | -$288.17K | SELL-OPTIONS | 4.94% | 41.46K | Feb 16 - Feb 17 | ||
Feb 18, 2021 | CHIEF ADMINISTRATIVE OFFICER | 1.98K | $142.66 | -$284.18K | SELL-OPTIONS | 36.84% | 7.35K | Feb 16 - Feb 17 | ||
Feb 18, 2021 | PRESIDENT AND CEO | 15.31K | $142.66 | -$2.26M | SELL-OPTIONS | 1.92% | 814.19K | Feb 16 - Feb 17 | ||
Feb 18, 2021 | SVP, HUMAN RESOURCES | 997.00 | $142.66 | -$147.37K | SELL-OPTIONS | 1.38% | 73.50K | Feb 16 - Feb 17 | ||
Feb 03, 2021 | PRESIDENT AND CEO | -66.09K | $138.07 | -$4.19M | SELL | -7.80% | 781.34K | Dec 28 - Feb 01 | ||
Jan 07, 2021 | PRESIDENT AND CEO | -31.81K | $128.74 | -$4.10M | SELL | -3.62% | 847.43K | Jan 04 | ||
Dec 14, 2020 | — | -20.00K | $132.06 | -$2.64M | SELL | -25.35% | 58.91K | Dec 14 | ||
Dec 02, 2020 | — | -30.58K | $124.56 | -$3.81M | SELL | -3.36% | 879.25K | Dec 01 | ||
Nov 03, 2020 | — | -32.82K | $121.11 | -$3.97M | SELL | -3.48% | 909.82K | Nov 02 | ||
Oct 02, 2020 | — | -27.43K | $103.55 | -$2.84M | SELL | -2.83% | 942.64K | Oct 01 | ||
Sep 28, 2020 | — | 0.00 | $60.77 | -$169.31K | OPTION EXERCISE | 0.00% | 2.02K | Sep 24 | ||
Sep 02, 2020 | — | -19.93K | $75.03 | -$1.50M | SELL | -2.01% | 970.07K | Sep 01 | ||
Aug 21, 2020 | — | -6.45K | $64.15 | -$610.35K | OPTION EXERCISE | -76.17% | 2.02K | Aug 19 | ||
Aug 04, 2020 | — | -15.00K | $51.62 | -$2.73M | OPTION EXERCISE | -40.68% | 21.87K | Jul 31 | ||
Aug 04, 2020 | — | -24.70K | $68.12 | -$2.34M | GRANT OR AWARD | -2.43% | 990.00K | Apr 30 - Aug 03 | ||
Aug 04, 2020 | — | -30.86K | $57.76 | -$3.37M | OPTION EXERCISE | -43.86% | 39.51K | Jul 31 | ||
Aug 04, 2020 | — | 0.00 | $51.65 | -$835.61K | OPTION EXERCISE | 0.00% | 15.02K | Jul 31 | ||
Aug 04, 2020 | — | 0.00 | $51.26 | -$1.80M | OPTION EXERCISE | 0.00% | 78.91K | Jul 31 | ||
Aug 04, 2020 | — | -2.54K | $94.00 | -$238.67K | SELL | -7.25% | 32.46K | Jul 31 | ||
Jul 30, 2020 | — | 10.46K | $94.78 | $969.68K | GRANT OR AWARD | 17.47% | 70.37K | Oct 30 - Jul 29 | ||
Jul 30, 2020 | — | -1.16K | $96.13 | -$111.90K | SELL | -1.45% | 78.91K | Jul 28 | ||
Apr 06, 2020 | — | 13.05K | $56.69 | -$677.33K | OPTION EXERCISE | 77.35% | 29.93K | Apr 02 - Apr 03 | ||
Mar 03, 2020 | — | -2.00K | $77.54 | -$155.08K | SELL | -5.81% | 32.44K | Feb 28 | ||
Mar 02, 2020 | — | 2.64K | $80.17 | -$191.05K | OPTION EXERCISE | 4.63% | 59.73K | Feb 27 - Feb 28 | ||
Mar 02, 2020 | — | 10.82K | $80.17 | -$781.66K | OPTION EXERCISE | 1.08% | 1.01M | Feb 27 - Feb 28 | ||
Feb 28, 2020 | — | 2.21K | $80.27 | -$84.36K | OPTION EXERCISE | 15.08% | 16.87K | Feb 26 - Feb 27 | ||
Feb 28, 2020 | — | 1.81K | $80.27 | -$130.60K | OPTION EXERCISE | 3.26% | 57.26K | Feb 26 - Feb 27 | ||
Feb 28, 2020 | — | 15.46K | $80.27 | -$1.11M | OPTION EXERCISE | 1.56% | 1.00M | Feb 26 - Feb 27 | ||
Feb 26, 2020 | — | 4.39K | $85.11 | -$417.89K | OPTION EXERCISE | 8.60% | 55.45K | Feb 24 - Feb 25 | ||
Feb 26, 2020 | — | 16.21K | $85.11 | -$1.54M | OPTION EXERCISE | 1.67% | 988.40K | Feb 24 - Feb 25 | ||
Feb 21, 2020 | — | -10.00K | $67.88 | -$2.11M | OPTION EXERCISE | -49.52% | 10.19K | Feb 19 | ||
Feb 20, 2020 | — | 2.50K | $100.68 | -$116.08K | OPTION EXERCISE | 1299.48% | 2.69K | Feb 18 - Feb 19 | ||
Jan 17, 2020 | — | -10.00K | $90.30 | -$903.00K | SELL | -32.27% | 20.99K | Jan 16 | ||
Nov 25, 2019 | GENERAL MANAGER - DIAGNOSTICS | -28.02K | $80.38 | -$2.25M | SELL | -39.27% | 43.32K | Nov 21 | ||
Sep 13, 2019 | SVP - RESEARCH AND DEVELOPMENT | 4.66K | $69.54 | -$362.25K | SELL-OPTIONS | 59.39% | 12.50K | Apr 30 - Sep 12 | ||
Aug 02, 2019 | DIRECTOR | -1.74K | $117.93 | -$205.67K | SELL | -2.20% | 77.51K | Jul 31 | ||
Aug 02, 2019 | DIRECTOR | -2.50K | $72.45 | -$522.20K | SELL | -21.90% | 8.91K | Jul 31 | ||
Aug 02, 2019 | DIRECTOR | 0.00 | $61.48 | -$4.79M | SELL-OPTIONS | 0.00% | 12.46K | Jul 31 | ||
Aug 02, 2019 | DIRECTOR | -2.81K | $117.93 | -$331.15K | SELL | -7.54% | 34.44K | Jul 31 | ||
Aug 02, 2019 | DIRECTOR | -10.00K | $117.65 | -$1.18M | SELL | -22.63% | 34.18K | Jul 31 | ||
Jul 31, 2019 | CHIEF FINANCIAL OFFICER | 9.27K | $83.10 | -$1.02M | SELL-OPTIONS | 22.29% | 50.88K | Apr 30 - Jul 30 | ||
Apr 04, 2019 | PRESIDENT, COLOGUARD | 13.81K | $92.54 | -$1.04M | SELL-OPTIONS | 2082.65% | 14.47K | Apr 02 - Apr 03 | ||
Mar 12, 2019 | CHIEF ADMINISTRATIVE OFFICER | 3.25K | $87.21 | -$241.93K | SELL-OPTIONS | 3.13% | 106.98K | Mar 09 - Mar 11 | ||
Mar 12, 2019 | PRESIDENT AND CEO | 13.17K | $87.21 | -$979.13K | SELL-OPTIONS | 1.33% | 1.00M | Mar 09 - Mar 11 | ||
Mar 01, 2019 | DIRECTOR | -25.00K | $92.81 | -$2.32M | SELL | -24.49% | 77.10K | Feb 28 | ||
Mar 01, 2019 | DIRECTOR | -500.00 | $96.00 | -$48.00K | SELL | -5.49% | 8.61K | Feb 28 | ||
Mar 01, 2019 | SVP - RESEARCH AND DEVELOPMENT | -1.17K | $93.20 | -$108.68K | SELL | -12.94% | 7.84K | Feb 28 | ||
Mar 01, 2019 | CHIEF FINANCIAL OFFICER | -2.45K | $93.20 | -$228.07K | SELL | -5.55% | 41.60K | Feb 28 | ||
Mar 01, 2019 | DIRECTOR | -2.00K | $96.00 | -$192.00K | SELL | -5.39% | 35.09K | Feb 28 | ||
Mar 01, 2019 | CHIEF ADMINISTRATIVE OFFICER | -2.45K | $93.20 | -$228.07K | SELL | -2.30% | 103.73K | Feb 28 | ||
Mar 01, 2019 | PRESIDENT AND CEO | -10.01K | $93.20 | -$933.34K | SELL | -1.00% | 990.54K | Feb 28 | ||
Mar 01, 2019 | DIRECTOR | -7.50K | $96.00 | -$720.00K | SELL | -15.31% | 41.48K | Feb 28 | ||
Feb 28, 2019 | CHIEF ADMINISTRATIVE OFFICER | 16.62K | $95.07 | -$932.01K | SELL-OPTIONS | 18.56% | 106.17K | Feb 26 - Feb 27 | ||
Feb 28, 2019 | PRESIDENT AND CEO | 31.43K | $95.07 | -$871.73K | SELL-OPTIONS | 3.24% | 1.00M | Feb 26 - Feb 27 | ||
Feb 26, 2019 | CHIEF FINANCIAL OFFICER | 4.86K | $90.55 | -$402.50K | SELL-OPTIONS | 14.21% | 39.03K | Feb 23 - Feb 25 | ||
Feb 26, 2019 | CHIEF ADMINISTRATIVE OFFICER | 6.71K | $90.55 | -$556.25K | SELL-OPTIONS | 8.10% | 89.55K | Feb 23 - Feb 25 | ||
Feb 26, 2019 | PRESIDENT AND CEO | 17.93K | $90.55 | -$1.49M | SELL-OPTIONS | 1.88% | 969.13K | Feb 23 - Feb 25 | ||
Jan 25, 2019 | CHIEF FINANCIAL OFFICER | 0.00 | $78.90 | -$7.17M | SELL-OPTIONS | 0.00% | 33.99K | Jan 23 - Jan 24 | ||
Jan 25, 2019 | CHIEF ADMINISTRATIVE OFFICER | 0.00 | $78.21 | -$13.23M | SELL-OPTIONS | 0.00% | 82.65K | Jan 23 - Jan 24 | ||
Jan 25, 2019 | PRESIDENT AND CEO | 0.00 | $81.27 | -$24.74M | SELL-OPTIONS | 0.00% | 951.20K | Jan 24 - Jan 25 | ||
Jan 04, 2019 | CHIEF ADMINISTRATIVE OFFICER | 3.11K | $62.75 | -$99.21K | SELL-OPTIONS | 3.90% | 82.65K | Jan 02 - Jan 03 | ||
Nov 14, 2018 | DIRECTOR | -4.09K | $36.22 | -$502.73K | SELL | -3.86% | 102.10K | Oct 31 - Nov 12 | ||
Nov 14, 2018 | PRESIDENT AND CEO | 3.57K | $34.97 | -$11.13M | SELL-OPTIONS | 0.38% | 951.20K | Apr 30 - Nov 12 | ||
Nov 07, 2018 | CHIEF SCIENCE OFFICER | -38.31K | $75.01 | -$2.87M | SELL | -48.28% | 41.04K | Nov 05 - Nov 07 | ||
Nov 02, 2018 | CHIEF SCIENCE OFFICER | -79.67K | $71.73 | -$5.71M | SELL | -50.10% | 79.35K | Oct 31 - Nov 01 | ||
Oct 10, 2018 | CHIEF SCIENCE OFFICER | -54.43K | $37.66 | -$4.00M | SELL | -25.50% | 159.02K | Apr 30 - Oct 08 | ||
Oct 02, 2018 | CHIEF ADMINISTRATIVE OFFICER | 2.50K | $79.51 | -$174.12K | SELL-OPTIONS | 3.24% | 79.55K | Sep 30 - Oct 01 | ||
Aug 30, 2018 | DIRECTOR | -2.47K | $74.85 | -$184.73K | SELL | -21.31% | 9.11K | Aug 28 | ||
Aug 01, 2018 | DIRECTOR | -2.85K | $58.86 | -$167.57K | SELL | -2.61% | 106.20K | Jul 30 | ||
Aug 01, 2018 | DIRECTOR | -2.37K | $58.86 | -$139.67K | SELL | -6.57% | 33.77K | Jul 30 | ||
Aug 01, 2018 | DIRECTOR | -1.32K | $58.86 | -$77.58K | SELL | -3.43% | 37.09K | Jul 30 | ||
Aug 01, 2018 | DIRECTOR | -3.43K | $58.86 | -$201.71K | SELL | -6.54% | 48.98K | Jul 30 | ||
Jul 31, 2018 | CHIEF FINANCIAL OFFICER | 11.44K | $35.52 | -$496.85K | SELL-OPTIONS | 52.51% | 33.24K | Apr 30 - Jul 30 | ||
Jul 03, 2018 | SVP AND GENERAL COUNSEL | 6.36K | $32.52 | -$103.53K | SELL-OPTIONS | 8.99% | 77.05K | Apr 30 - Jul 02 | ||
May 11, 2018 | DIRECTOR | -7.40K | $51.53 | -$381.45K | SELL | -40.28% | 10.97K | May 10 | ||
Apr 13, 2018 | DIRECTOR | -7.23K | $45.00 | -$325.44K | SELL | -6.40% | 105.81K | Apr 12 | ||
Apr 12, 2018 | DIRECTOR | -3.10K | $40.97 | -$126.93K | SELL | -8.09% | 35.18K | Apr 10 | ||
Apr 12, 2018 | DIRECTOR | -8.45K | $39.73 | -$335.63K | SELL | -13.88% | 52.41K | Apr 10 | ||
Apr 03, 2018 | SVP AND GENERAL COUNSEL | 2.57K | $40.12 | -$85.12K | SELL-OPTIONS | 3.77% | 70.69K | Mar 31 - Apr 02 | ||
Mar 13, 2018 | CHIEF SCIENCE OFFICER | 0.00 | $37.68 | -$613.07K | SELL-OPTIONS | 0.00% | 206.29K | Mar 09 - Mar 13 | ||
Mar 13, 2018 | SVP AND GENERAL COUNSEL | 3.32K | $52.19 | -$141.34K | SELL-OPTIONS | 5.12% | 68.12K | Mar 09 - Mar 12 | ||
Mar 13, 2018 | PRESIDENT AND CEO | 12.94K | $52.19 | -$598.09K | SELL-OPTIONS | 1.38% | 947.63K | Mar 09 - Mar 12 | ||
Mar 13, 2018 | COO | 5.98K | $52.19 | -$276.37K | SELL-OPTIONS | 0.92% | 658.61K | Mar 09 - Mar 12 | ||
Feb 28, 2018 | COO | 6.64K | $44.10 | -$243.07K | SELL-OPTIONS | 1.03% | 652.63K | Feb 26 - Feb 27 | ||
Feb 28, 2018 | CHIEF SCIENCE OFFICER | -7.79K | $25.32 | -$1.36M | SELL | -3.56% | 211.15K | Feb 26 - Feb 27 | ||
Feb 28, 2018 | SVP AND GENERAL COUNSEL | 12.11K | $44.10 | -$409.76K | SELL-OPTIONS | 22.98% | 64.81K | Feb 26 - Feb 27 | ||
Feb 28, 2018 | PRESIDENT AND CEO | 10.94K | $44.10 | -$400.63K | SELL-OPTIONS | 1.18% | 934.69K | Feb 26 - Feb 27 | ||
Feb 27, 2018 | CHIEF SCIENCE OFFICER | 12.65K | $31.06 | -$670.25K | SELL-OPTIONS | 6.13% | 218.94K | Feb 23 - Feb 26 | ||
Feb 27, 2018 | CHIEF FINANCIAL OFFICER | 6.32K | $42.34 | -$126.25K | SELL-OPTIONS | 40.83% | 21.79K | Feb 23 - Feb 26 | ||
Feb 27, 2018 | SVP AND GENERAL COUNSEL | 8.43K | $42.34 | -$187.13K | SELL-OPTIONS | 19.04% | 52.70K | Feb 23 - Feb 26 | ||
Feb 27, 2018 | PRESIDENT AND CEO | 28.51K | $42.34 | -$1.07M | SELL-OPTIONS | 3.18% | 923.75K | Feb 23 - Feb 26 | ||
Feb 27, 2018 | COO | 17.52K | $42.34 | -$522.96K | SELL-OPTIONS | 2.79% | 646.00K | Feb 23 - Feb 26 | ||
Feb 13, 2018 | PRESIDENT AND CEO | 0.00 | $23.28 | -$4.56M | SELL-OPTIONS | 0.00% | 895.24K | Feb 09 | ||
Jan 25, 2018 | PRESIDENT AND CEO | 0.00 | $25.66 | -$5.48M | SELL-OPTIONS | 0.00% | 895.24K | Jan 23 | ||
Jan 17, 2018 | PRESIDENT AND CEO | 0.00 | $26.81 | -$6.52M | SELL-OPTIONS | 0.00% | 895.24K | Jan 12 | ||
Jan 04, 2018 | SVP AND GENERAL COUNSEL | 4.70K | $29.24 | -$77.47K | SELL-OPTIONS | 11.99% | 43.94K | Oct 31 - Jan 03 | ||
Dec 26, 2017 | PRESIDENT AND CEO | 0.00 | $26.71 | -$6.39M | SELL-OPTIONS | 0.00% | 895.24K | Dec 22 | ||
Dec 08, 2017 | PRESIDENT AND CEO | 0.00 | $27.14 | -$6.41M | SELL-OPTIONS | 0.00% | 895.24K | Dec 06 | ||
Dec 04, 2017 | CHIEF SCIENCE OFFICER | -45.77K | $58.27 | -$2.67M | SELL | -18.18% | 205.96K | Dec 01 | ||
Nov 22, 2017 | PRESIDENT AND CEO | 0.00 | $30.17 | -$7.87M | SELL-OPTIONS | 0.00% | 895.24K | Nov 21 | ||
Nov 13, 2017 | PRESIDENT AND CEO | 10.00 | $29.98 | -$8.04M | SELL-OPTIONS | 0.00% | 895.24K | Nov 09 | ||
Nov 03, 2017 | CHIEF SCIENCE OFFICER | -45.77K | $53.60 | -$2.45M | SELL | -15.39% | 251.73K | Nov 01 | ||
Oct 03, 2017 | CHIEF SCIENCE OFFICER | -45.77K | $30.56 | -$3.33M | SELL | -13.33% | 297.51K | Oct 02 | ||
Oct 03, 2017 | SVP AND GENERAL COUNSEL | -24.43K | $47.16 | -$1.37M | SELL | -38.37% | 39.24K | Sep 29 - Oct 02 | ||
Sep 07, 2017 | CHIEF SCIENCE OFFICER | 42.32K | $25.78 | -$1.82M | SELL-OPTIONS | 14.06% | 343.28K | Sep 05 - Sep 06 | ||
Sep 05, 2017 | CHIEF SCIENCE OFFICER | -45.77K | $41.49 | -$1.90M | SELL | -13.20% | 300.97K | Sep 01 | ||
Aug 18, 2017 | DIRECTOR | 2.50K | $37.71 | $94.28K | BUY | 4.28% | 60.86K | Aug 17 | ||
Aug 01, 2017 | CHIEF FINANCIAL OFFICER | 12.90K | $39.41 | -$230.39K | SELL-OPTIONS | 815.16% | 14.49K | Jul 28 - Jul 31 | ||
Jul 05, 2017 | SVP AND GENERAL COUNSEL | 6.37K | $20.58 | -$48.14K | SELL-OPTIONS | 11.11% | 63.67K | May 01 - Jul 03 | ||
Apr 04, 2017 | SVP AND GENERAL COUNSEL | 3.15K | $23.74 | -$36.63K | SELL-OPTIONS | 5.81% | 57.30K | Mar 31 - Apr 03 | ||
Mar 14, 2017 | CHIEF SCIENCE OFFICER | -2.94K | $21.16 | -$62.32K | SELL | -0.85% | 343.17K | Mar 13 | ||
Mar 14, 2017 | SVP AND GENERAL COUNSEL | -1.98K | $21.16 | -$41.96K | SELL | -3.53% | 54.15K | Mar 13 | ||
Mar 14, 2017 | PRESIDENT AND CEO | -12.06K | $21.16 | -$255.17K | SELL | -1.35% | 882.43K | Mar 13 | ||
Mar 14, 2017 | COO | -5.57K | $21.16 | -$117.95K | SELL | -0.89% | 621.34K | Mar 13 | ||
Feb 28, 2017 | CHIEF SCIENCE OFFICER | 8.48K | $21.51 | -$186.43K | SELL-OPTIONS | 2.58% | 337.69K | Feb 24 - Feb 27 | ||
Feb 28, 2017 | SVP AND GENERAL COUNSEL | 14.35K | $21.48 | -$151.35K | SELL-OPTIONS | 40.14% | 50.11K | Feb 26 - Feb 27 | ||
Feb 28, 2017 | PRESIDENT AND CEO | 12.39K | $21.51 | -$583.52K | SELL-OPTIONS | 1.44% | 870.09K | Feb 24 - Feb 27 | ||
Feb 28, 2017 | COO | 12.04K | $21.50 | -$238.97K | SELL-OPTIONS | 1.99% | 615.64K | Feb 24 - Feb 27 | ||
Jan 05, 2017 | SVP AND GENERAL COUNSEL | 4.71K | $9.78 | -$11.62K | SELL-OPTIONS | 15.59% | 34.92K | Oct 31 - Jan 03 | ||
Dec 14, 2016 | DIRECTOR | 10.00K | $13.84 | $138.40K | BUY | 7.91% | 136.38K | Dec 14 | ||
Nov 15, 2016 | CHIEF SCIENCE OFFICER | 872.00 | $10.17 | -$4.53M | SELL-OPTIONS | 0.34% | 257.26K | Oct 31 - Nov 15 | ||
Nov 15, 2016 | PRESIDENT AND CEO | 33.08K | $9.36 | -$9.68M | SELL-OPTIONS | 4.11% | 838.32K | Nov 11 - Nov 15 | ||
Nov 15, 2016 | COO | 0.00 | $9.15 | -$9.36M | SELL-OPTIONS | 0.00% | 596.38K | Nov 11 - Nov 15 | ||
Oct 04, 2016 | SVP AND GENERAL COUNSEL | 2.99K | $17.98 | -$30.58K | SELL-OPTIONS | 10.97% | 30.21K | Sep 30 - Oct 03 | ||
Sep 06, 2016 | DIRECTOR | 5.00K | $18.10 | $90.50K | BUY | 4.30% | 121.25K | Sep 01 | ||
Aug 05, 2016 | DIRECTOR | 3.38K | $17.93 | $60.61K | BUY | 3.30% | 105.93K | Aug 03 | ||
Jul 27, 2016 | CHIEF SCIENCE OFFICER | 20.08K | $10.38 | -$94.76K | SELL-OPTIONS | 8.50% | 256.38K | May 02 - Jul 26 | ||
Jul 27, 2016 | COO | 17.64K | $14.82 | -$109.06K | SELL-OPTIONS | 3.05% | 596.38K | Jul 25 - Jul 26 | ||
Jul 05, 2016 | SVP AND GENERAL COUNSEL | 5.37K | $9.12 | -$6.35K | SELL-OPTIONS | 24.56% | 27.22K | May 02 - Jul 01 | ||
Apr 04, 2016 | SVP AND GENERAL COUNSEL | 3.00K | $6.62 | -$11.15K | SELL-OPTIONS | 15.93% | 21.85K | Mar 31 - Apr 01 | ||
Mar 11, 2016 | SVP AND GENERAL COUNSEL | 3.85K | $6.05 | -$13.16K | SELL-OPTIONS | 25.67% | 18.85K | Mar 09 - Mar 10 | ||
Mar 11, 2016 | CHIEF SCIENCE OFFICER | 5.38K | $6.05 | -$18.40K | SELL-OPTIONS | 2.33% | 236.30K | Mar 09 - Mar 10 | ||
Mar 11, 2016 | COO | 7.23K | $6.05 | -$24.45K | SELL-OPTIONS | 2.21% | 334.17K | Mar 09 - Mar 10 | ||
Mar 08, 2016 | DIRECTOR | 5.00K | $6.43 | $32.15K | BUY | 30.38% | 21.46K | Mar 08 | ||
Mar 04, 2016 | DIRECTOR | 3.77K | $5.38 | $20.30K | BUY | 4.33% | 91.00K | Mar 03 | ||
Mar 01, 2016 | PRESIDENT AND CEO | 50.00K | $5.00 | $250.00K | BUY | 7.11% | 753.10K | Mar 01 | ||
Feb 29, 2016 | PRESIDENT AND CEO | -6.89K | $5.81 | -$40.06K | SELL | -0.97% | 703.10K | Feb 26 | ||
Feb 26, 2016 | CHIEF SCIENCE OFFICER | 5.25K | $5.52 | -$16.54K | SELL-OPTIONS | 2.33% | 230.92K | Feb 24 - Feb 25 | ||
Feb 26, 2016 | COO | 6.90K | $5.52 | -$22.63K | SELL-OPTIONS | 2.16% | 326.94K | Feb 24 - Feb 25 | ||
Feb 24, 2016 | CHIEF SCIENCE OFFICER | 4.81K | $6.39 | -$15.41K | SELL-OPTIONS | 2.18% | 225.67K | Feb 22 - Feb 23 | ||
Feb 24, 2016 | PRESIDENT AND CEO | 12.51K | $6.39 | -$43.87K | SELL-OPTIONS | 1.85% | 690.49K | Feb 22 - Feb 23 | ||
Feb 24, 2016 | COO | 4.67K | $6.39 | -$16.33K | SELL-OPTIONS | 1.48% | 320.03K | Feb 22 - Feb 23 | ||
Jan 13, 2016 | DIRECTOR | 15.00K | $6.99 | $104.85K | BUY | 15.75% | 110.21K | Jan 11 | ||
Jan 06, 2016 | SVP AND GENERAL COUNSEL | 11.68K | $9.05 | -$64.02K | SELL-OPTIONS | 1459.50% | 12.48K | Jan 04 - Jan 05 | ||
Jan 05, 2016 | PRESIDENT AND CEO | 7.19K | $8.72 | -$93.74K | SELL-OPTIONS | 1.78% | 412.06K | Feb 18 - Jan 04 | ||
Jan 05, 2016 | COO | 3.12K | $8.72 | -$30.08K | SELL-OPTIONS | 1.26% | 250.37K | Dec 31 - Jan 04 | ||
Jan 05, 2016 | CHIEF SCIENCE OFFICER | 4.34K | $8.22 | -$20.62K | SELL-OPTIONS | 2.03% | 218.33K | Nov 01 - Jan 04 | ||
Jul 28, 2015 | CHIEF SCIENCE OFFICER | 13.40K | $20.91 | -$284.94K | SELL-OPTIONS | 6.68% | 213.99K | Apr 30 - Jul 27 | ||
Jul 28, 2015 | COO | 15.67K | $24.04 | -$224.34K | SELL-OPTIONS | 8.63% | 197.25K | Jul 25 - Jul 27 | ||
Jul 28, 2015 | PRESIDENT AND CEO | 14.81K | $20.91 | -$252.47K | SELL-OPTIONS | 4.81% | 322.52K | Apr 30 - Jul 27 | ||
Feb 26, 2015 | DIRECTOR | 4.31K | $23.44 | -$92.31K | SELL-OPTIONS | 2.19% | 200.77K | Feb 24 - Feb 26 | ||
Feb 26, 2015 | PRESIDENT AND CEO | 11.07K | $23.44 | -$197.48K | SELL-OPTIONS | 4.40% | 262.58K | Feb 24 - Feb 26 | ||
Feb 26, 2015 | COO | 7.11K | $23.44 | -$91.30K | SELL-OPTIONS | 5.94% | 126.72K | Feb 24 - Feb 26 | ||
Feb 25, 2015 | DIRECTOR | 3.19K | $22.90 | -$92.45K | SELL-OPTIONS | 1.65% | 196.45K | Feb 23 - Feb 24 | ||
Feb 25, 2015 | PRESIDENT AND CEO | 9.58K | $22.90 | -$224.37K | SELL-OPTIONS | 3.96% | 251.51K | Feb 23 - Feb 24 | ||
Feb 25, 2015 | COO | 4.23K | $22.90 | -$68.59K | SELL-OPTIONS | 3.67% | 119.62K | Feb 23 - Feb 24 | ||
Jan 05, 2015 | CHIEF SCIENCE OFFICER | -337.00 | $17.27 | -$86.27K | SELL | -0.17% | 195.83K | Oct 31 - Jan 02 | ||
Jan 05, 2015 | COO | 5.35K | $17.27 | -$56.67K | SELL-OPTIONS | 4.86% | 115.39K | May 08 - Jan 02 | ||
Jan 05, 2015 | PRESIDENT AND CEO | 7.84K | $26.72 | -$253.41K | SELL-OPTIONS | 3.35% | 241.93K | Mar 14 - Jan 02 | ||
Oct 29, 2014 | CHIEF SCIENCE OFFICER | -8.02K | $24.68 | -$197.81K | SELL | -3.93% | 196.16K | Oct 29 | ||
Oct 20, 2014 | DIRECTOR | 0.00 | $13.85 | -$1.61M | SELL-OPTIONS | 0.00% | 212.34K | Oct 16 - Oct 20 | ||
Oct 20, 2014 | CHIEF SCIENCE OFFICER | 75.00K | $13.18 | -$2.87M | SELL-OPTIONS | 58.06% | 204.18K | Oct 16 - Oct 20 | ||
Oct 20, 2014 | COO | 80.00K | $12.16 | -$5.54M | SELL-OPTIONS | 84.18% | 175.04K | Oct 16 - Oct 20 | ||
Oct 20, 2014 | PRESIDENT AND CEO | 135.00K | $12.16 | -$8.95M | SELL-OPTIONS | 82.27% | 299.09K | Oct 16 - Oct 20 | ||
Jul 29, 2014 | SR. VP, CHIEF SCIENCE OFFICER | 15.15K | $11.90 | -$167.60K | SELL-OPTIONS | 13.28% | 129.18K | Oct 31 - Jul 25 | ||
Jul 29, 2014 | COO | 19.04K | $11.90 | -$122.56K | SELL-OPTIONS | 25.05% | 95.04K | Oct 31 - Jul 25 | ||
Jul 29, 2014 | PRESIDENT AND CEO | 16.39K | $11.90 | -$160.01K | SELL-OPTIONS | 11.09% | 164.09K | Apr 30 - Jul 25 | ||
May 06, 2014 | SVP, FINANCE & PFO | 12.52K | $11.29 | $141.43K | BUY | 317.82% | 16.46K | Apr 30 - May 05 | ||
Feb 25, 2014 | SR. VP, CHIEF SCIENCE OFFICER | 4.07K | $14.07 | -$44.46K | SELL-OPTIONS | 3.58% | 117.61K | Feb 22 - Feb 24 | ||
Feb 25, 2014 | COO | 4.56K | $14.07 | -$37.45K | SELL-OPTIONS | 6.39% | 76.00K | Feb 22 - Feb 24 | ||
Feb 25, 2014 | PRESIDENT AND CEO | 10.67K | $14.07 | -$122.52K | SELL-OPTIONS | 7.51% | 152.63K | Feb 22 - Feb 24 | ||
Jan 03, 2014 | SR. VP, CHIEF SCIENCE OFFICER | 6.95K | $11.96 | -$123.04K | SELL-OPTIONS | 6.62% | 111.90K | Nov 18 - Jan 02 | ||
Jan 03, 2014 | COO | 1.47K | $11.96 | -$103.18K | SELL-OPTIONS | 2.14% | 70.18K | Dec 31 - Jan 02 | ||
Jan 03, 2014 | PRESIDENT AND CEO | 31.86K | $11.96 | -$315.49K | SELL-OPTIONS | 29.36% | 140.37K | Dec 31 - Jan 02 | ||
Oct 30, 2013 | SR. VP, CHIEF SCIENCE OFFICER | -7.43K | $11.07 | -$82.25K | SELL | -6.61% | 104.95K | Oct 28 | ||
Sep 24, 2013 | DIRECTOR | 0.00 | $8.04 | -$207.50K | SELL-OPTIONS | 0.00% | 203.87K | Sep 20 | ||
Nov 02, 2012 | PRESIDENT AND CEO | 4.70K | $6.42 | $50.07K | BUY | 6.11% | 81.48K | Mar 05 - Nov 02 | ||
Nov 02, 2012 | COO AND CFO | 5.20K | $6.16 | $32.06K | BUY | 14.35% | 41.44K | Apr 30 - Nov 02 | ||
Nov 02, 2012 | DIRECTOR | 5.50K | $9.08 | $49.94K | BUY | 8.36% | 71.27K | Nov 01 | ||
Apr 24, 2012 | DIRECTOR | 20.00K | $8.16 | $163.28K | BUY | 72.81% | 47.47K | Dec 13 | ||
Nov 23, 2010 | PRESIDENT AND CEO | 6.00K | $5.62 | $33.72K | BUY | 13.73% | 49.69K | Nov 23 | ||
Aug 20, 2010 | SENIOR VP AND CFO | -2.50K | $4.14 | -$10.35K | p | -12.27% | 17.88K | Aug 20 | ||
Aug 19, 2010 | DIRECTOR | 2.00K | $4.27 | $8.55K | BUY | 3.35% | 61.78K | Aug 17 | ||
Aug 17, 2010 | DIRECTOR | 5.00K | $4.32 | $21.60K | BUY | 9.13% | 59.78K | Aug 13 | ||
Aug 09, 2010 | DIRECTOR | 50.00K | $4.25 | $212.50K | BUY | 857.49% | 55.83K | Aug 06 | ||
Aug 05, 2010 | PRESIDENT AND CEO | 4.00K | $4.26 | $17.04K | BUY | 10.08% | 43.69K | Aug 04 | ||
May 12, 2010 | PRESIDENT AND CEO | 3.58K | $4.22 | $15.11K | BUY | 9.91% | 39.69K | May 10 | ||
Feb 18, 2010 | SR. VP & CFO | 2.50K | $3.98 | $9.96K | BUY | 45.83% | 7.96K | Feb 18 | ||
Sep 01, 2009 | PRESIDENT & CEO | 9.00K | $2.22 | $19.98K | BUY | ∞ | 9.00K | Aug 31 | ||
Nov 05, 2003 | EXECUTIVE VICE PRESIDENT | -50.00K | $10.52 | -$526.13K | SELL | -61.73% | 31.00K | Nov 03 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.